Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#416 most reported symptom for this vaccine
Anti-cyclic citrullinated peptide antibody positive has been reported 4 times in association with FLUX(H1N1) vaccination in VAERS.
Among these reports, 0 mentioned death (0.00%) and 0 involved hospitalization (0.0%).
Anti-cyclic citrullinated peptide antibody positive is the #416 most frequently reported symptom for FLUX(H1N1) out of 521 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 4 reports of Anti-cyclic citrullinated peptide antibody positive after FLUX(H1N1) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.